NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/30/2023
Back to search
Official data from USPTO
PHARMACEUTICAL INDUSTRY PULSE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMACEUTICAL INDUSTRY PULSE
ST13
US500000085611541Class
42
Filing
85611541
Registration
4267694
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
12/30/2023
Trademark type
Word
Nice classes
42
Filing date
04/30/2012
Registration date
01/01/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/30/2023
Last transaction
12/30/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/08/1996
First use in commerce
07/08/1996
Drawing code
4
Owner type
03
Owner location
NEW YORK, NY
Examiner
ARANT, LUCY
Law office
M20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
COWEN INC.
Cowen Group, Inc.
Representatives
Mary S. Mathew Dentons US LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing on-line publicationsnewslettersjournals and research reports containing advicearticles and information of interest to investorsparticipants and trade members in the pharmaceutical industry
Publications
History of USPTO decisions and trademark events.
34 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/30/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/30/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/30/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/07/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
07/03/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/01/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/28/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/28/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/28/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/27/2018
E815
TEAS SECTION 8 & 15 RECEIVED
12/27/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/01/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/12/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/25/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
01/01/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/16/2012
PUBO
PUBLISHED FOR OPPOSITION
10/16/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/26/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/07/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
08/28/2012
ALIE
ASSIGNED TO LIE
08/27/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/27/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
08/27/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/27/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/23/2012
GNRT
NON-FINAL ACTION E-MAILED
08/23/2012
CNRT
NON-FINAL ACTION WRITTEN
08/23/2012
DOCK
ASSIGNED TO EXAMINER
08/20/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/04/2012
NWAP
NEW APPLICATION ENTERED
05/03/2012
Continuous trademark protection
Get notified about every new filing that threatens PHARMACEUTICAL INDUSTRY PULSE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.